Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

@article{Hanauer2002MaintenanceIF,
  title={Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial},
  author={S. Hanauer and B. Feagan and G. Lichtenstein and L. Mayer and T. A. I. S. Group},
  journal={The Lancet},
  year={2002},
  volume={359},
  pages={1541-1549}
}
  • S. Hanauer, B. Feagan, +2 authors T. A. I. S. Group
  • Published 2002
  • Medicine
  • The Lancet
  • BACKGROUND We did a randomised controlled trial to assess the benefit of maintenance infliximab therapy in patients with active Crohn's disease who respond to a single infusion of infliximab. [...] Key MethodMETHODS 573 patients with a score of at least 220 on the Crohn's disease activity index (CDAI) received a 5 mg/kg intravenous infusion of infliximab at week 0.Expand Abstract

    Figures, Tables, and Topics from this paper.

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The utility of capsule endoscopy in diagnosing small bowel (SB) Crohn's disease has been demonstrated in a number of studies. Mucosal healing is a good predictor of long term… Expand
    ConditionsCrohn's Disease
    InterventionDevice
    OBSERVATIONAL CLINICAL TRIAL
    Crohn's disease (CD) is a lifelong condition of inflammation in the bowel. CD can affect any part of the gastrointestinal tract from mouth to anus. Symptoms can include: tiredness… Expand
    ConditionsCrohn's Disease, Inflammatory Bowel Disease
    InterventionBiological
    OBSERVATIONAL CLINICAL TRIAL
    The purpose of this study is to develop a predictive model that will allow optimized dosing of infliximab for individual patients  
    ConditionsCrohn's Disease, Ulcerative Colitis
    INTERVENTIONAL CLINICAL TRIAL
    To investigate whether sustained trough levels of IFX can be achieved using IFX (Infliximab) trough level measurements and adjustment of dosing based upon these levels by means of two… Expand
    ConditionsCrohn's Disease
    InterventionDrug
    Retrieval of Serum Infliximab Level by Shortening the Maintenance Infusion Interval Is Correlated with Clinical Efficacy in Crohn's Disease
    • 50
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 39 REFERENCES
    Long term safety of infliximab.
    • 110
    • PDF
    Maintenance therapy in Crohn's disease.
    • 23
    • PDF